Roche CEO Sev­erin Schwan is keep­ing his hand on the bud­get ax

Just a few weeks af­ter Roche brought out the ax and chopped more than 200 jobs out of Genen­tech in an un­usu­al cost-cut­ting move in R&D for the phar­ma gi­ant, CEO Sev­erin Schwan is like­ly rais­ing some added ten­sions with a pledge to root out in­ef­fi­cien­cies.

In an in­ter­view with Reuters that will be close­ly read to­day by the rank and file, Schwan said that the com­pa­ny is stream­lin­ing its glob­al busi­ness units in a move that will af­fect “scores of jobs.”

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.